An Introduction to Multiple-dose Study Dose and dose regimen are some of the features that need to...

  WASHINGTON, May 8, 2023 /PRNewswire/ -- MCRA, LLC, a leading medical device focused regulatory advisory firm and clinical research organization (CRO) integrating...

Clinical Trials Day is an annual celebration that honors the contributions of volunteers, researchers, and healthcare professionals. Those who work tirelessly to advance medical...

As a clinical research organization (CRO), you know the importance of choosing the right sites for your clinical trials. The success of your trials...

March 1, 2023 The advent of outsourcing in clinical research came about in the 1980s based on transactional business-to-business interactions, which...

ProRelix Research is the best clinical research organization (CRO) with global service capability supporting Phase 1, 2, 3, & 4 clinical trials for Pharma,...

Clinical research is how new drugs and treatments are validated, tested, and improved. It’s a long and detailed process that involves testing drugs...

MCRA, LLC, a leading medical device focused regulatory advisory firm and clinical research organization integrating U.S. and International Regulatory Affairs, Clinical Trial Operations, Reimbursement and Market Access, Healthcare Compliance, Cybersecurity, and Quality Assurance support, is pleased to announce its recent acquisition of Vorpal Technologies K.K.

VANCOUVER, B.C. — Brains Bioceutical Corp (“Brains Bio” or the “Company”), a global leader in pharmaceutical EU-GMP grade Cannabidiol (CBD) Active Pharmaceutical Ingredient (API), is pleased to announce the initiation of […]

Well-tolerated with No Serious Adverse Findings BERWYN, Pa.–(BUSINESS WIRE)–#pharma—Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders, and anti-viral indications, reported positive results of four preclinical dermal safety studies for Epoladerm™ (diclofenac epolamine). Epoladerm is an investigational product candidate for the management of […]